Life After Stents & Bypass: Circulation, Recovery Context, and EECP Evidence

EVIDENCE BOX — CLAIM 3

EECP after stents or bypass: Preliminary mixed-population evidence

Evidence tier: Preliminary. Directly relevant evidence exists because studies of EECP for angina include people who had previously undergone coronary revascularization. However, the available records are mainly mixed-population registry or before-and-after studies. They do not provide a dedicated, sham-controlled comparison of EECP specifically for people after stenting or CABG, and they do not establish an effect on stent patency, graft patency, recurrent coronary events, or recovery after a recent procedure. Evidence type | What the record directly reports | Limits on interpretation International EECP Patient Registry (IEPR), voluntary observational registry | In 978 people beginning EECP for angina at participating centers, 81% had been previously revascularized and 69% were considered unsuitable for PCI or CABG when EECP began. Of participants completing a usual 35-hour course, 81% reported improvement of at least one Canadian Cardiovascular Society angina class immediately after the last treatment. | This was a voluntary, uncontrolled registry, with data collected before treatment and at treatment completion. It did not randomize participants, use a sham comparison, separately report outcomes for prior stent versus prior CABG groups, specify time since revascularization, or test stent/graft patency or future events. The result therefore cannot establish a causal, procedure-specific benefit. Prospective pre-test/post-test cohort, mixed severe coronary disease population | A 2020 study enrolled 220 people with coronary artery disease receiving EECP; 24 participants had a history of CABG. The cohort’s Seattle Angina Questionnaire-7 quality-of-life score was higher at three-month follow-up than before EECP. | This was a single-center, consecutive-sampling, before-and-after study without a parallel control or sham group. The CABG subgroup was small and outcomes were not reported separately for it. It included no dedicated post-stent group analysis and did not test graft patency, restenosis, cardiovascular events, or long-term recovery. MUST-EECP randomized, blinded, controlled trial — adjacent-condition evidence | In 139 outpatients with symptomatic coronary artery disease and a positive treadmill test, active and inactive counterpulsation were compared over four to seven weeks. Active treatment increased time to at least 1-mm ST-segment depression versus inactive treatment and was associated with more decreases in angina episodes. | This is stronger study design evidence for symptomatic coronary artery disease and angina, but it did not report a distinct after-stent or after-CABG population or outcomes by revascularization history. It is adjacent-condition evidence, not condition-specific efficacy evidence for this page. Total exercise duration and between-group nitroglycerin-use differences were not significant in the primary report. What the tier means: The direct post-revascularization evidence is preliminary, not a basis to claim that EECP treats, cures, prevents, reverses, or is indicated for life after stents or bypass. The cited studies do not establish that EECP prevents restenosis, keeps a stent open, keeps a graft open, substitutes for evaluation or revascularization, or improves survival or other future cardiovascular outcomes after PCI or CABG. A person’s timing after a procedure, symptoms, medicines, vascular anatomy, and other health factors are outside this educational page.^[9][10][11]